L1 M1 of LDCT for Low Muscle Mass Measurement

Sponsor
Far Eastern Memorial Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04547478
Collaborator
(none)
3,304
1
17.6
187.6

Study Details

Study Description

Brief Summary

The first lumbar spine muscle index (L1 MI) on computed tomography (CT) obtained by measuring muscle surface at the first lumbar vertebrae (L1) level is an indicator of total skeletal mass in specific populations. Nevertheless, the utility of L1 MI derived from low dose chest CT (LDCT) in health assessments and relevant cutoff points are unclear.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: low dose chest CT(LDCT)

Study Design

Study Type:
Observational
Actual Enrollment :
3304 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Evaluation of Low Muscle Mass by Muscle Surface Index of First Lumbar Vertebrae Using Low Dose Computed Tomography
Actual Study Start Date :
Jan 21, 2019
Actual Primary Completion Date :
Apr 20, 2020
Actual Study Completion Date :
Jul 10, 2020

Outcome Measures

Primary Outcome Measures

  1. Cross sectional muscle area of the 1st vertebrae level [52 weeks]

    Cross sectional muscle area of the 1st vertebrae level by LDCT

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults older than 20 years who received LDCT in routine health assessments from January to December 2017 were enrolled at a tertiary care hospital (Far Eastern Memorial Hospital, New Taipei City, Taiwan).
Exclusion Criteria:
  • nil

Contacts and Locations

Locations

Site City State Country Postal Code
1 Far Eastern Memorial Hospital New Taipei Taiwan 220

Sponsors and Collaborators

  • Far Eastern Memorial Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT04547478
Other Study ID Numbers:
  • IRB-107091-E
First Posted:
Sep 14, 2020
Last Update Posted:
Sep 14, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2020